Back to the main directory
Press Release
- Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2024 and Provides Update on the Cytisinicline Development Program by GlobeNewsWire
- Biogen Initiates Phase 3 Study of Felzartamab for the Treatment of Late Antibody-Mediated Rejection (AMR) in Kidney Transplant Patients by GlobeNewsWire
- Bioventus Announces Fourth Quarter and Full Year 2024 Financial Results by GlobeNewsWire
- Jeffs’ Brands Enters Into a Definitive Agreement to Acquire a U.S. Company that Operates a U.S. Based Logistics Center, aiming to Advance its Growth Strategy, for $2.6 million by GlobeNewsWire
- EQS-News: centrotherm-Konzern übertrifft nach vorläufigen Zahlen durch eine Verdopplung des EBITDA auf rund 39 Mio. EUR seine Ergebnisprognose für das Geschäftsjahr 2024 by EQS Group AG
- EQS-News: The NAGA Group: Investment Note von Montega verfügbar – Nach transformativem Zusammenschluss profitables Wachstum voraus by EQS Group AG
- The Board of Directors of Harvia Plc have decided on a new performance period for the Long-term Performance Share Plan for the key employees by GlobeNewsWire
- Net Asset Value(s) by GlobeNewsWire
- X4 Pharmaceuticals to Report Fourth-Quarter and Full-Year 2024 Financial Results and Host a Conference Call and Webcast on March 25, 2025 by GlobeNewsWire
- YY Group Holding Limited's First Overseas Market to Achieve Rapid Growth, YY Circle Malaysia, Secures Six Deals, Expanding Revenue Pipeline to US$13 Million for 2025 by GlobeNewsWire
- Corbus Pharmaceuticals Reports Q4 and 2024 Financial Results and Provides a Corporate Update by GlobeNewsWire
- Abacus Life Announces Rebrand to Abacus Global Management, Unveils Expanded Business Lines by GlobeNewsWire
- Annovis Joins Experts at Drug Development Summit to Redefine Parkinson's Treatment by GlobeNewsWire
- zSpace Acquires BlocksCAD to Revolutionize 3D Design and STEM Education by GlobeNewsWire
- Baker Hughes, NextDecade Enter Framework Agreement for Rio Grande LNG Expansion Trains by GlobeNewsWire
- Core Molding Technologies Reports Full Year and Fourth Quarter 2024 Results by GlobeNewsWire
- Sagimet Biosciences Announces Clearance of IND for FASN Inhibitor TVB-3567, to be Developed for the Treatment of Acne by GlobeNewsWire
- Madrigal Appoints Jacqualyn A. Fouse, Ph.D. to Its Board of Directors by GlobeNewsWire
- Brera Holdings Hosts Inaugural Investor Weekend at its Italian Serie B Football Club Juve Stabia, 'The Second Team of Naples,' Showcasing Sport, Culture, and Strategic Growth by GlobeNewsWire
- LENZ Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights on March 19, 2025 by GlobeNewsWire
- Enphase Energy Launches Next-Generation IQ EV Charger across Europe by GlobeNewsWire
- Teladoc Health Expands Connected Care Partnerships by GlobeNewsWire
- Ovid Therapeutics Reports Business Updates and Fourth Quarter and Full Year 2024 Financial Results by GlobeNewsWire
- Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Post-Traumatic Stress Disorder to take Place at Massachusetts General Hospital by GlobeNewsWire
- StoneX to Acquire The Benchmark Company, Adding Capabilities in Investment Banking by GlobeNewsWire